Key result
Activating PPARalpha and PPARgamma induces CLA-1/SR-BI expression in human macrophages and murine atherosclerotic lesions.
Why the study?
The role and regulation of CLA-1/SR-BI expression in macrophages within atherosclerotic lesions and its modulation by PPAR activators were not fully understood.
Does PPAR activation increase CLA-1/SR-BI expression in macrophages and atherosclerotic lesions?
Does PPAR activation increase CLA-1/SR-BI expression in macrophages and atherosclerotic lesions?
Answers are grounded in this paper and cite their sources.
PPAR activation induces CLA-1/SR-BI expression in macrophages, suggesting a role for PPARs in cholesterol homeostasis within atherosclerotic lesions.
BACKGROUND: The scavenger receptors are cell-surface receptors for native and modified lipoproteins that play a critical role in the accumulation of lipids by macrophages. CLA-1/SR-BI binds HDL with high affinity and is involved in the cholesterol reverse-transport pathway. Peroxisome proliferator-activated receptors (PPARs) are transcription factors regulating the expression of genes implicated in lipid metabolism, cellular differentiation, and inflammation. Here, we investigated the expression of CLA-1/SR-BI in macrophages and its regulation by PPARs. METHODS AND RESULTS: CLA-1 is undetectable in human monocytes and is induced upon differentiation into macrophages. Immunohistological analysis on human atherosclerotic lesions showed high expression of CLA-1 in macrophages of the lipid core colocalizing with PPARalpha and PPARgamma staining. Activation of PPARalpha and PPARgamma resulted in the induction of CLA-1 protein expression in monocytes and in differentiated macrophages. Finally, SR-BI expression is increased in atherosclerotic lesions of apoE-null mice treated with either PPARgamma or PPARalpha ligands. CONCLUSIONS: Our data demonstrate that CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and induced by PPAR activation, identifying a potential role for PPARs in cholesterol homeostasis in atherosclerotic lesion macrophages.
No takes yet. Share an insight, caveat, or question.
Chinetti et al. (2000) studied Atherosclerosis. PPARalpha and PPARgamma ligands was evaluated on CLA-1/SR-BI expression in macrophages. Activation of PPARalpha and PPARgamma induced CLA-1/SR-BI expression in human monocytes/macrophages and in atherosclerotic lesions of apoE-null mice.
Synapse has enriched 10 related papers. Consider them for comparative context: